Dataset for amiodarone adverse events compared to placebo using data from randomized controlled trials

被引:5
作者
Moroi, Morgan K. [1 ]
Ruzieh, Mohammed [2 ]
Aboujamous, Nader M. [3 ]
Ghahramani, Mehrdad [2 ]
Naccarelli, Gerald V. [2 ]
Mandrola, John [4 ]
Foy, Andrew J. [2 ]
机构
[1] Penn State Coll Med, Hershey, PA USA
[2] Penn State Heart & Vasc Inst, 500 Univ Dr,POB 850,MC H047, Hershey, PA 17033 USA
[3] Penn State Dept Internal Med, Hershey, PA USA
[4] Baptist Hlth Louisville, Louisville, KY USA
来源
DATA IN BRIEF | 2020年 / 28卷
关键词
Amiodarone; Adverse events; Toxicity; LOW-DOSE AMIODARONE; ATRIAL-FIBRILLATION; INTRAVENOUS AMIODARONE; RECENT-ONSET; ORAL AMIODARONE; SINUS RHYTHM; PREVENTION; TERMINATION; EFFICACY; FAILURE;
D O I
10.1016/j.dib.2019.104835
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The dataset presented here provides a detailed description of the adverse events of amiodarone versus placebo using data from 43 randomized controlled trials. Two authors (M.M., M.R.) independently extracted the data. The dataset also includes baseline patient characteristics, amiodarone loading and maintenance doses, as well as forest plots describing the relative risk (RR) of developing an adverse event related to the pulmonary, thyroid, hepatic, cardiac, skin, gastrointestinal, neurological, and ocular systems. The Mantel-Haenszel random effects model was used to determine the relative risk of adverse events of amiodarone compared to placebo. This dataset is complementary to our article "Meta-analysis Comparing the Relative Risk of Adverse Events for Amiodarone Versus Placebo", which was published in the American Journal of Cardiology [1]. The data can be used to assess certain adverse events and their relation to amiodarone loading and/or maintenance dose. (C) 2019 The Author(s). Published by Elsevier Inc.
引用
收藏
页数:25
相关论文
共 20 条
  • [1] Comparison of intravenously administered dofetilide versus amiodarone in the acute termination of atrial fibrillation and flutter - A multicentre, randomized, double-blind, placebo-controlled study
    Bianconi, L
    Castro, A
    Dinelli, M
    Alboni, P
    Pappalardo, A
    Richiardi, E
    Santini, M
    [J]. EUROPEAN HEART JOURNAL, 2000, 21 (15) : 1265 - 1273
  • [2] Conversion of recent onset paroxysmal atrial fibrillation to normal sinus rhythm: the effect of no treatment and high-dose amiodarone - A randomized, placebo-controlled study
    Cotter, G
    Blatt, A
    Kaluski, E
    Metzkor-Cotter, E
    Koren, M
    Litinski, I
    Simantov, R
    Moshkovitz, Y
    Zaidenstein, R
    Peleg, E
    Vered, Z
    Golik, A
    [J]. EUROPEAN HEART JOURNAL, 1999, 20 (24) : 1833 - 1842
  • [3] Preoperative amiodarone as prophylaxis against atrial fibrillation after heart surgery
    Daoud, EG
    Strickberger, SA
    Man, KC
    Goyal, R
    Deeb, GM
    Bolling, SF
    Pagani, FD
    Bitar, D
    Meissner, MD
    Morady, F
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (25) : 1785 - 1791
  • [4] DONOVAN KD, 1995, AM J CARDIOL, V75, P693, DOI 10.1016/S0002-9149(99)80655-9
  • [5] Morbidity and mortality following early administration of amiodarone in acute myocardial infarction
    Elizari, MV
    Martínez, JM
    Belziti, C
    Ciruzzi, M
    de la Hoz, RP
    Sinisi, A
    Carbajales, J
    Scapín, O
    Garguichevich, J
    Girotti, L
    Cagide, A
    [J]. EUROPEAN HEART JOURNAL, 2000, 21 (03) : 198 - 205
  • [6] Intravenous amiodarone in treatment of recent-onset atrial fibrillation: Results of a randomized, controlled study
    Galve, E
    Rius, T
    Ballester, R
    Artaza, MA
    Arnau, JM
    GarciaDorado, D
    SolerSoler, J
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1996, 27 (05) : 1079 - 1082
  • [7] Effect of low dose amiodarone on the incidence of sudden death in elderly patients with congestive heart failure: A double-bind, placebo-controlled study
    Gentile, S
    Vignoli, A
    Tommasielli, G
    Gualdiero, P
    Mirra, G
    Manzella, D
    Varricchio, A
    Simeone, D
    Varricchio, M
    [J]. ARCHIVES OF GERONTOLOGY AND GERIATRICS, 1996, : 191 - 195
  • [8] Oral amiodarone for prevention of atrial fibrillation after open heart surgery, the Atrial Fibrillation Suppression Trial (AFIST): a randomised placebo-controlled trial
    Giri, S
    White, CM
    Dunn, AB
    Felton, K
    Freeman-Bosco, L
    Reddy, P
    Tsikouris, JP
    Wilcox, HA
    Kluger, J
    [J]. LANCET, 2001, 357 (9259) : 830 - 836
  • [9] INTRAVENOUS AMIODARONE IN ACUTE ANTERIOR MYOCARDIAL-INFARCTION - A CONTROLLED-STUDY
    GRECO, R
    DALTERIO, D
    SCHIATTARELLA, M
    MUSTO, B
    WOLFF, S
    BOCCIA, AS
    MININNI, N
    [J]. CARDIOVASCULAR DRUGS AND THERAPY, 1989, 2 (06) : 791 - 794
  • [10] BENEFICIAL-EFFECTS OF LOW-DOSE AMIODARONE IN PATIENTS WITH CONGESTIVE CARDIAC-FAILURE - A PLACEBO-CONTROLLED TRIAL
    HAMER, AWF
    ARKLES, LB
    JOHNS, JA
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1989, 14 (07) : 1768 - 1774